While the possibility of ACE inhibitor-induced permeability and/or angioedema due to elevated kinin levels has been raised, ACE inhibitors have nonetheless generated interest and shown promise for DR/DME treatment [126,127,128]. This evidence concerns the gene ACE and angioedema.